drugset / Trial / NCT00524160

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis

NCT00524160 ↗

Phase 4 Completed 264 enrolled Janssen Pharmaceutica N.V., Belgium
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the degree of pain control achieved by treatment with fentanyl, administered via adhesive patches applied to the skin ('transdermal system") in patients with rheumatoid arthritis or osteoarthritis of the knee or hip. Treatment will be administered fo r4 weeks, added on to existing therapy with other medications.

Timeline

Start
2001-07
Primary completion
—
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 25 ug Other
Subject Fentanyl Other / unclassified 100 ug Other